GPT Healthcare Ltd

GPT Healthcare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 30 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 05 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

GPT Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 30 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 August 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

GPT Healthcare Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late June 2026. Despite a recent dip in price, the stock’s underlying indicators suggest a complex interplay of forces that investors should carefully analyse before making decisions.

GPT Healthcare Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend as of late June 2026. This micro-cap hospital sector stock is showing promising signs of strength, supported by key technical indicators such as MACD, moving averages, and Bollinger Bands, signalling potential upside for investors.

GPT Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 30 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

GPT Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent dip in price, the stock’s underlying technical indicators reveal a complex interplay of bullish and bearish signals, warranting a closer examination for investors navigating this evolving landscape.

GPT Healthcare Ltd has demonstrated a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is supported by a confluence of technical indicators including MACD, moving averages, and Bollinger Bands, signalling potential upside for investors amid a micro-cap hospital sector environment.

GPT Healthcare Ltd has witnessed a notable upgrade in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a shift in price attractiveness amid evolving market dynamics. This micro-cap hospital sector player’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more compelling investment case relative to its historical averages and peer group, signalling renewed investor interest despite recent price volatility.

GPT Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent 3.9% decline in its share price to ₹163.75, the stock’s technical indicators reveal a complex interplay of signals that investors should carefully analyse amid broader market dynamics.

GPT Healthcare Ltd has demonstrated a marked improvement in its financial performance for the quarter ended June 2026, shifting from a flat to a positive growth trajectory. The hospital sector micro-cap has posted robust revenue growth and margin expansion, signalling renewed investor confidence and operational efficiency gains.

GPT Healthcare Ltd., the Kolkata-based hospital chain, reported a modest sequential decline in net profit for Q1 FY27, posting ₹12.73 crores compared to ₹14.57 crores in Q4 FY26, representing a 12.63% quarter-on-quarter decline. However, the year-on-year comparison reveals a more encouraging picture, with net profit surging 65.76% from ₹7.68 crores in Q1 FY26, driven by robust revenue expansion.

GPT Healthcare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 30 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 August 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trends, and technical outlook.

GPT Healthcare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 30 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

GPT Healthcare Ltd has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, driven by improved price-to-earnings and price-to-book value metrics relative to its historical averages and peer group. Despite a recent dip in share price, the hospital sector micro-cap presents compelling investment potential backed by strong return ratios and favourable valuation multiples.

GPT Healthcare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 30 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 12 July 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.